Myasthenia gravis, an autoimmune manifestation of lymphoma and lymphoproliferative disorders: case reports and review of literature (Q37921751)

25 August 2017

1 reference

title

Myasthenia gravis, an autoimmune manifestation of lymphoma and lymphoproliferative disorders: case reports and review of literature (English)

1 reference

lymphoproliferative disorders

25 August 2017

0 references

1 reference

Kourosh Rezania

1 reference

25 August 2017

Betty Soliven

1 reference

25 August 2017

Joseph Baron

1 reference

25 August 2017

Helen Lin

1 reference

25 August 2017

Vikram Penumalli

1 reference

25 August 2017

Koen van Besien

1 reference

25 August 2017

publication date

29 September 2011

1 reference

25 August 2017

1 reference

25 August 2017

1 reference

25 August 2017

1 reference

25 August 2017

page(s)

371-380

1 reference

The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK.

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.615426

Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.615426

Myasthenia gravis: the specificities of skeletal muscle and thymus antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.615426

Rare association of Hodgkin lymphoma, Graves' disease and myasthenia gravis complicated by post-radiation neurofibrosarcoma: coincidence or genetic susceptibility?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.615426

Striational antibodies in myasthenia gravis: reactivity and possible clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.615426

The pathology of the thymus gland in myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.615426

Myasthenia gravis: past, present, and future

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.615426

Paraneoplastic myasthenia gravis: immunological and clinical aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.615426

Myasthenia gravis in association with allogeneic bone marrow transplantation: clinical observations, therapeutic implications and review of literature

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.615426

Idiopathic thrombocytopenic purpura and myasthenia gravis after fludarabine treatment for chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.615426

Association of myasthenia gravis with extrathymic Hodgkin's lymphoma: complete resolution of myasthenic symptoms following antineoplastic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.615426

Myasthenia gravis and Waldenström's macroglobulinemia: a case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.615426

Myasthenia gravis and lymphoma. A clinical and immunological association

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.615426

Response of myasthenia gravis to rituximab in a patient with non-Hodgkin lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.615426

Myasthenia gravis and monoclonal IgG gammopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.615426

Multiple myeloma in a patient with systemic lupus erythematosus, myasthenia gravis and non-familial diffuse palmoplantar keratoderma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.615426

Multistep pathogenesis of autoimmune disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.615426

The risk of lymphoma development in autoimmune diseases: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.615426

The dual association between lymphoma and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.615426

Auto-immune manifestations in Non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.615426

Malignant lymphoma-associated autoimmune diseases--a descriptive epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.615426

Autoimmunity and extranodal lymphocytic infiltrates in lymphoproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.615426

Thymocytes and cultured thymic epithelial cells express transcripts encoding alpha-3, alpha-5, and beta-4 subunits of neuronal nicotinic acetylcholine receptors. Preferential transcription of the alpha-3 and beta-4 genes by immature CD4+8+ thymocyte

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.615426

Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.615426

Determination of acetylcholine receptor antibody in myasthenia gravis: clinical usefulness and pathogenetic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.615426

The natural autoantibodies system: between hypotheses and facts

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.615426

Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.615426

Prednisolone treatment induces tolerogenic dendritic cells and a regulatory milieu in myasthenia gravis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.615426

The role of FoxP3+CD4+CD25hi Tregs in the pathogenesis of myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.615426

Paraneoplastic pemphigus: an association with fludarabine?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.615426

Autoimmunity and malignancy in hematology--more than an association

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.615426

Myasthenia gravis accompanied by alopecia areata: clinical and immunogenetic aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.615426

Neuromuscular junction autoimmune disease: muscle specific kinase antibodies and treatments for myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.615426

Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.615426

The Lambert-Eaton myasthenic syndrome. A review of 50 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.615426

Lymphoma and peripheral neuropathy: a clinical review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.615426

Treatment of autoimmune myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.615426

Successful treatment of MuSK antibody-positive myasthenia gravis with rituximab

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.615426

Complete remission induced by rituximab in refractory, seronegative, muscle-specific, kinase-positive myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.615426

Rituximab in the management of refractory myasthenia gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.615426

Rituximab for the treatment of thymoma-associated and de novo myasthenia gravis: 3 cases and review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.615426

A Case of Malignant Lymphoma and Myasthenia Gravis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.615426

Myasthenia gravis with a monoclonal gammopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.615426

Non-Hodgkin malignant lymphomas and peripheral neuropathies—13 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2011.615426

10.3109/10428194.2011.615426

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference